Universe Pharmaceuticals Inc (UPC): Operating Cash Flow

Annual figures by period end, from SEC filings.

Figures out of scale. In this company's filings, reported revenue for the year ended 2023-09-30 is more than 100 times total assets. That usually means a value was tagged in the wrong unit. Figures are shown as filed; growth rates are not computed, and the company is left out of screens and comparisons.

-$5.05B
Year ended 2025-09-30. As filed; likely tagged in the wrong unit
$1.12B2019-09-30: $13.20M2020-09-30: $6.12M2021-09-30: -$2.06M2022-09-30: -$1.30M2023-09-30: $1.12B2024-09-30: -$9.51B2025-09-30: -$5.05B-$5.05B
2019-09-30 Operating Cash Flow (USD) 2025-09-30
Period endedOperating Cash FlowChange YoYSource filing
2025-09-30-$5.05Bn/a2026-01-29, From 2024-10-01
2024-09-30-$9.51Bn/a2026-01-29, From 2023-10-01
2023-09-30$1.12Bn/a2026-01-29, From 2022-10-01
2022-09-30-$1.30Mn/a2025-04-29, From 2021-10-01
2021-09-30-$2.06Mn/a2024-01-30, From 2020-10-01
2020-09-30$6.12Mn/a2023-02-10, From 2019-10-01
2019-09-30$13.20Mn/a2022-01-31, From 2018-10-01